Immuneering
Christian Alaia is a finance professional with extensive experience in Financial Planning and Analysis (FP&A). Currently serving as Senior Director of FP&A at Immuneering Corporation since June 2021, Christian previously held the role of Director of FP&A at Gilead Sciences from November 2020 to June 2021, supporting both Commercial and General & Administrative functions. Prior to Gilead, Christian was a Manager of FP&A at Immunomedics from August 2018 until its acquisition in November 2020. Additional experience includes positions as Senior Financial Analyst at Sanofi and Senior Accounting Specialist at SaxBST. Christian began a career in finance as a Financial Services Intern at BST Financial and Management Consultants. Christian holds a Bachelor of Science degree in Accounting from the University at Albany.
This person is not in any teams
This person is not in any offices
Immuneering
1 followers
Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.